4baseCare

4baseCare

Bangalore, India· Est.

AI-powered precision oncology platform leveraging global genomic diversity to deliver personalized cancer diagnostics and treatment insights.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

AI-powered precision oncology platform leveraging global genomic diversity to deliver personalized cancer diagnostics and treatment insights.

Oncology

Technology Platform

AI-powered platform (OncoTwin) that integrates multi-modal genomic data (tissue, liquid biopsy, germline) with real-world clinical data and the Global Cancer Diversity Atlas to deliver personalized treatment insights and support clinical decision-making.

Opportunities

Expansion into global markets via partnerships, leveraging their unique diverse genomic dataset for pharma R&D and drug discovery collaborations, and scaling AI-powered clinical decision support tools for molecular tumor boards worldwide.

Risk Factors

Competition from large global diagnostic players, regulatory hurdles in new geographic markets, and the challenge of maintaining data quality and clinical utility as their dataset scales.

Competitive Landscape

Competes with global diagnostic firms (e.g., Foundation Medicine, Guardant Health) and local Indian labs, but differentiates through its focus on genomic diversity from underrepresented populations, integrated SoLiQ testing approach, and AI-powered OncoTwin platform for real-world evidence generation.